Could Magellan Financial Group Ltd be the top financial growth stock of 2014?

Magellan Financial Group Ltd (ASX:MFG) has an enviable track record of growth.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Magellan Financial Group Ltd (ASX: MFG) has been one of the top performing stocks on the ASX over the past eight years with the share price up around 500% since listing in December 2006.

The share price growth is not unfounded. The fund manager – which was established by CEO and portfolio manager Hamish Douglass – began life with funds under management (FUM) of around $400 million. Since then the group, which focuses on global equities and infrastructure strategies, has not only grown thanks to impressive portfolio returns, but it has also attracted billions more in FUM.

As at August 2014 total FUM stood at $25 billion!

With the focus on buying shares in very large global companies such as eBay Inc and Microsoft, Magellan has the capacity to manage billions more. In fact, management openly states that they believe their strategies and structure can support a current theoretical capacity of US$50 billion in FUM.

Early mover advantage

Despite the tiny size of the ASX as a percentage of global equities – the ASX only represents around 2.5% of the global MSCI Index – most Australians have an excessive skew towards domestic shares.

Investors and advisors finally appear to be awakening to the opportunity that international investing adds. This has left a number of domestic funds scrambling to offer global capabilities to their clients, a service Magellan has become a leader in.

Top Stock

Magellan's outstanding share price appreciation appears to have caused the stock to run out of puff in the last 12 months. Despite hefty growth in FUM, the share price gains have been more muted, although still good with the one-year return from Magellan being 12% which certainly beats the S&P/ASX 200's (INDEXASX: XJO) 4% rise.

This slowdown could be a positive for long-term investors as it has arguably allowed the value of the company to catch up to its roaring share price. Now could be an appealing entry point into a company which could very well be described as the top financial stock not just of 2014, but also of the past eight years.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »